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Abstract 
Background: In India, since July 2012, at designated Microscopy Centers (DMCs) in 200 medical colleges, sputum 
smear examination for tuberculosis bacilli changed from Ziehl Neelsen (ZN) method to auramine based Light Emit-
ting Diode Fluorescent Microscopy (LED-FM) method. We assessed the additional yield of smear positives among 
patients undergoing follow-up sputum examination during TB treatment before and after deploying LED-FM.
Methods: This was a before and after comparison study in eight conveniently selected medical college DMCs across 
North India. We extracted data from TB laboratory registers on number of TB patients examined for follow-up and 
their smear microscopy results including the grades by ZN (before; July–December 2011) and LED-FM (after; July–
December 2012) and compared them.
Results: Altogether, 2868 TB patients were examined by LED-FM and 2740 were examined by ZN during follow-up. 
LED-FM increased the proportion of follow-up smear positives from 5.0 % (n = 136) to 7.4 % (n = 213) with an addi-
tional yield of 77 follow-up smear-positives—with the highest increase in smears graded scanty (2.6 vs 1.2 %) (p value 
<0.05).
Conclusions: Since all smear positives during follow-up are considered ‘presumptive multidrug resistant (MDR)-TB 
patients’ in India, introduction of LED-FM would result in additional number of patients eligible for MDR-TB testing, 
which would have otherwise been missed by ZN.
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Background
The World Health Organization (WHO) recommends 
phasing-in Light Emitting Diode Fluorescent Micros-
copy (LED-FM) as an alternative to conventional 
Ziehl-Neelsen microscopy (ZN) for diagnosis of smear-
positive pulmonary tuberculosis (TB) [1]. Many studies 
in controlled laboratory settings have shown that LED-
FM is about 10 % more sensitive and as specific as ZN in 
detecting TB bacillus on smear microscopy [2]. In India, 
since July 2012 under the Revised National Tuberculo-
sis Control Programme, the sputum smear examination 
for TB bacilli at designated microscopy centers (DMCs) 
in 200 medical colleges, changed from ZN method to 
auramine based LED-FM method. LED-FM has been 
shown to increase the detection of smear positive tuber-
culosis under routine programmatic conditions [3].
Unlike at the time of diagnosis, TB patients who 
undergo follow-up sputum smear examination during 
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TB treatment, produce less sputum and are mostly pauci-
bacillary [4]. There is no evidence from India if use of 
LED-FM increases the detection of smear positives 
among patients undergoing follow-up sputum smear 
examination under routine programmatic conditions. In 
this study, we evaluated whether implementation of LED-
FM increased the yield of smear positives during follow-
up and discuss its programmatic implications.
Methodology
We conducted a before and after comparison study in 
eight conveniently selected medical colleges in North 
India that were implementing LED-FM services. The 
study sample included all TB patients who underwent 
follow-up sputum smear examination in these colleges 
during the period July–December 2012 (using LED-FM) 
and July–December 2011 (using ZN microscopy). TB 
patients, as a part of monitoring their response to treat-
ment, undergo follow-up smear examination at the end 
of intensive phase, 2  months into continuation phase 
and at the end of treatment. Those found to be sputum 
smear positive are evaluated for drug resistance. Patient 
details, reasons for sputum smear examination (whether 
for diagnosis or for follow-up) and results are recorded 
in the TB laboratory register. For this study, we included 
all patients who under-went follow-up sputum smear 
examination conducted during the two study periods. 
We reviewed the TB laboratory registers and abstracted 
aggregate data on number of TB patients examined for 
follow-up and their smear microscopy results including 
grades.
LED-FM and ZN procedures were performed by 
trained laboratory technicians. As per programme guide-
lines, smears were prepared from direct sputum speci-
mens in both techniques. Briefly, for LED-FM, the heat 
fixed smears were flooded with 0.1  % auramine phe-
nol for 7–10  min, rinsed with running water, decolor-
ized with 3  % acid alcohol for 2  min twice, rinsed with 
running water, counter stained with 0.1  % potassium 
permanganate for 30  s, rinsed with running water and 
air dried [4]. For ZN microscopy, the heat fixed smears 
were flooded with 1  % carbol fuchsin for 5  min, rinsed 
gently with running water, decolorized with 25 % sulphu-
ric acid for 2–4 min, rinsed with water, counter stained 
with 0.1 % methylene blue for 30 s, rinsed with running 
water and air dried [5]. Trained laboratory technicians 
prepared and examined the smears and reported the 
results as shown in Table 1 [3]. The microscopy centers 
performed smear microscopy procedures under a system 
of external quality assurance which included onsite visits 
by dedicated laboratory supervisors and periodic, ran-
dom blinded rechecking of smears [6, 7]. As per national 
guidelines, two smears are required to be examined for 
follow up examinations [6]. Patient will be labelled as 
smear positive at follow-up if at least one smear is posi-
tive irrespective of the grades. If both smears are positive, 
the higher microscopy grade is used for reporting. As per 
the newer national guidelines on programmatic man-
agement of drug resistant TB, all TB patients who are 
smear positive during follow-up at the end of 2 months 
of intensive phase and/or 5 months of continuous phase 
(depending upon the districts) are considered as ‘pre-
sumptive  multidrug resistant (MDR)-TB patients’ and 
are investigated for Rifampicin and Isoniazid resistance 
using culture and drug susceptibility test (CDST) [8]. If 
patients are confirmed to be having strains that are resist-
ant to Rifampicin in vitro, they are treated using WHO-
recommended standardized second line regimen.
The number of TB patients examined during follow-up 
and proportion found smear positive was computed, sep-
arately for LED-FM and ZN microscopy. Chi squared test 
was used to test statistical significance (p-value ≤0.05) 
(SPSS v16). Ethics approval for this study was obtained 
from the Ethics Advisory Group of International Union 
Against Tuberculosis and Lung Disease (The Union).
Results
Of 2868  TB patients examined by LED-FM during fol-
low-up, 213 (7.4  %) were smear-positive and of 2740 
examined by ZN, 136 (5.0  %) were smear-positive—an 
Table 1 Guidelines of reporting sputum smear microscopy adopted by National Tuberculosis Control Programme in India
* HPF high power field
IUATLD/WHO scale (1000 × field = HPF*)  
Grades
Ziehl Neelsen (ZN) microscopy (1000 ×  
magnification: 1 length = 2 cm = 100 HPF)
LED-Fluorescence microscopy (400 ×  
magnification: 1 length = 40 fields = 200 HPF)
Negative Zero AFB/1 length Zero AFB/1 length
Positive
Scanty 1–9 AFB/1 length or 100 HPF 1–19 AFB/1 length or 100 HPF
1+ grade 10–99 AFB/1 length or 100 HPF 20–199 AFB/1 length
2+ grade 1–10 AFB/1 HPF on average 5–50 AFB/1 HPF on average
3+ grade >10 AFB/1 HPF on average >50 AFB/1 HPF on average
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additional yield of 77 follow-up smear-positives. The 
disaggregated results of first and second specimens are 
shown in Table  2. The additional yield of second speci-
men (negative on first specimen and positive only on sec-
ond specimen) was 12.5 % with ZN microscopy whereas 
it was 21.6 % with LED-FM (p = 0.3).
Compared to the before period, in the after-period 
there was a 5  % increase in the number of TB patients 
who underwent follow-up sputum smear examination. 
However, the number of TB patients found to be sputum 
smear positive rose by more than 50 % (Table 2). Apply-
ing 5.0 % positivity (observed in 2011) for the additional 
number of patients examined in 2012, LED-FM services 
still resulted in an additional yield of 71 follow-up smear-
positives. Most of the increase was noted in smears 
graded scanty followed by 3+ (p-value < 0.05) (Table 3). 
The direct yield was higher by LED-FM in most (n = 7) 
sites compared.
Discussion
This is the first study from India examining the impact 
of LED-FM on the sputum-positivity during follow-up 
of TB patients under routine programmatic settings. 
The increase in yield by LED-FM could be due to (1) 
increased absorbability of mycolic acid and damaged 
bacilli to auramine than fuschin, (2) the LED-FM stained 
background of slide is brighter, making it easier for labo-
ratory technicians to focus and examine slides with fewer 
bacilli and (3) increased area of the slide examined [7, 
9]. Since these findings come from a setting of quality-
assured smear microscopy under routine programmatic 
settings, they are most likely to be accurate and reflect 
operational realities and importantly during the period of 
study external quality assurance did not yield any major 
errors.
These results have important programme implications. 
LED-FM leads to an increase in the number of TB patients 
who will be identified as “presumptive MDR-TB patients” 
who will require CDST with consequent increase in labo-
ratory workload. Several studies in the past have shown 
that nearly two-thirds of the smear positives during fol-
low-up were culture negative, especially so if the smears 
are graded scanty, which most likely represent dead, non-
viable bacilli, yet to be excreted out of the body [10, 11]. 
Hence, it is not clear if increase in identification of follow-
up smear-positives using LED-FM is actually beneficial 
in enhancing detection of MDR-TB cases or just unnec-
essary additional workload for the CDST laboratories. 
Since we do not have information on culture results in 
our study, the possibility of false positive results could not 
Table 2 Performance of LED-FM (July–December 2012) in comparison to ZN microscopy (July–December 2011) in detect-
ing AFB during follow-up of TB patients in eight medical colleges of India
ZN Ziehl Neelsen Microscopy, LED-FM light emitting diode fluorescence microscopy, AFB acid fast bacilli, PP first and second smear positive, PN first smear positive and 
second smear negative, NP first smear negative and second smear positive
# p value < 0.001
^ p value = 0.03
Technique Number  
examined
Number smear  
positive





ZN 2740 136 110 9 17 5.0 % 12.5 %
LED-FM 2868 213 149 18 46 7.4 % 21.6 %
Absolute increase (rela-
tive increase)
+128 (4.7 %) +77 (56.6 %) +2.4 % (48 %)
Table 3 Comparison between Ziehl Neelson (ZN) and Light Emitting Diode-Fluorescence Microscopic technique (LED-FM) 
in detecting AFB (by smear quantification) during follow-up of TB patients in eight medical colleges of India
ZN Ziehl Neelsen Microscopy, LED-FM light emitting diode fluorescence microscopy, AFB acid fast bacilli
Smear grade of patient ZN Microscopy 2011 LED-FM 2012 Change in percentage (95 % CI) p-value
n1 % n2 %
Negative 2604 95.0 2655 92.6 −2.4 (−1.1 to −3.7) <0.0001
Positive Scanty 33 1.2 75 2.6 1.4 (0.7–2.0) 0.0001
1+ 57 2.1 78 2.7 0.6 (−0.1 to 1.4) 0.14
2+ 29 1.1 27 0.9 −0. 2 (−0. 7 to 0. 4) 0.45
3+ 17 0.6 33 1.1 0.5 (0.0 to 1.0) 0.01
Total 2740 100.0 2868 100.0 – –
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be assessed and should be a topic for future studies. To 
avoid this ‘smear-positive culture-negative’ phenomenon 
and increase the specificity of smear microscopy during 
follow-up, The Union in their TB guidelines recommend 
that all follow-up smear-positives (especially that done 
during month 5) in the first sample be reconfirmed by a 
second positive smear using an early morning sputum 
sample before declaring as ‘treatment failure’ and start 
next steps including investigation for MDR-TB [11]. A 
recent study from Chennai showed that if only one of the 
two smears was positive, this is most likely to be scanty 
and hence culture negative [12]. Adopting the Union’s 
approach would mean that TB patients who are positive 
on both the smears only would be investigated for MDR-
TB and would thus reduce unnecessary workload. The 
other alternatives to reduce unnecessary cultures are to 
use new methods like vital staining with fluorescein diac-
etate or slide culture, but these are not widely available or 
validated under routine conditions [13–15].
There were a few limitations to this study. It would have 
been better if the same samples were processed with the 
two methods. However, this could not be performed as 
the ZN microscopy system was already replaced with the 
LED-FM microscopy in the study sites. The culture and 
DST results were unavailable and hence it could not be 
found out if use of LED-FM actually increased the detec-
tion of MDR-TB cases. As in all pre-post designs, it is 
difficult to attribute the entire change to the interven-
tion (LED-FM) as there could be other undocumented 
changes (for example, pre-treatment smear positivity) 
during the study period. While we do not suspect this, 
we have no data to rule it out completely and is one of 
the limitations. Also the study did not disaggregate the 
follow-up smears at end of intensive phase and end of 
treatment. Since the study was conducted in conveniently 
selected medical colleges, there may be difficulties in 
generalizing the results to whole of India. Further studies 
should collect data countrywide or from a representative 
sample to confirm these results and act upon them.
Conclusions
Implementation of LED-FM led to increase in identifi-
cation of follow-up smear-positives among TB patients, 
mostly graded scanty. This has important resource impli-
cations for the TB programme in India.
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